Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Angler who wrote (5584)	2/21/1998 8:41:00 PM
From: MissLil	Read Replies (1) \| Respond to of 23519

From Reader's Digest, an influential medical journal: "Impotence Update: The first oral medicine for impotence, ...could be on the market in the next few months.... Current treatments can have some drawbacks: implants require surgery; vacuum-style devices can interrupt lovemaking; and injecting or inserting drugs into the penis can be uncomfortable. Soon three experimental oral medicine may alleviate the discomfort and embarrassment of these traditional therapies for some patients: Sildenafil blocks an enzyme in the penis that otherwise destroys a chemical produced during sexual stimulation. The longer that chemical stays around, the better chance of an erection. Apomorphine affects centers in the brain associated with initiating erections Phentolamine is a oral version of an injected medicine that allows dilation of penile blood vessels, causing an erection. Some patients who have tried the drugs say they work easily-and have few side effects. For more information contact the American Foundation for Urologic Disease at 800-473-0616, or check the Web at www.iiem.org. Comment: It is my understanding that phentolamine and apomorphine are reasonably far from approval. I don't believe either has an NDA filed. This would suggest that this is another coupe from the crack PR team at Pfizer. Free advertising. Have a note in Reader's Digest, people ask their docs about the "pill," and surprise! only Viagra is available (conveniently approved soon after this note.) What do you think, am I correct? I think Vivus ought to offer the PR people at Pfizer a lot of money to work for them. PR is FREE; ads cost a lot of money.